Wastewater Surveillance Network to Monitor Disease Threats During 2025 North American World Cup
A multidisciplinary surveillance network coordinated by Georgetown University and MedStar Health will monitor wastewater and other data sources across 16 host cities during the 2026 FIFA World Cup to detect disease outbreaks early. The effort aims to track pathogens including measles, COVID-19, influenza, and emerging threats like Ebola and dengue fever among the millions of international attendees. Early detection through wastewater monitoring can provide days or weeks of advance warning before clinical cases spike, allowing public health officials time to implement containment measures.
The Health Security Operations Center, a partnership between Georgetown University and MedStar Health led by Rebecca Katz, will conduct real-time disease surveillance during the 2026 World Cup across the United States, Mexico, and Canada. The network, which began operations on June 1, coordinates dozens of health organizations, research groups, biotech companies (including Verily Health), genomics labs, and local public health departments to monitor wastewater for pathogenic DNA and RNA. The system will prioritize tracking measles—which has already surpassed 2,000 cases in the U.S. this year—along with SARS-CoV-2, influenza, Ebola, and mosquito-borne illnesses. Daily reports will be distributed to over 350 enrolled organizations including hospital emergency managers, city health departments, and tournament organizers. Wastewater monitoring can detect community disease spread days or weeks before hospital cases spike, providing critical time for isolation, vaccination, and treatment efforts. The center also serves as a pilot for future mass-gathering health security at events like the 2028 Los Angeles Olympics.
How coverage differed
Scientific American emphasizes the scientific methodology and public health coordination challenges, including the U.S. withdrawal from the WHO and strained federal resources. The Washington Times focuses more on the operational scope and technological innovation, and notably highlights that the federal government allocated $625 million for law enforcement security but zero for public health measures, framing this as a gap that private and institutional funding must fill.
What different sources said
- Scientific AmericanCenter
The World Cup could be a petri dish for disease. Wastewater could sound the alarm
- Washington TimesRight
Georgetown team to track spread of infectious disease at World Cup
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.